Amarin Financials
This page shows Amarin (AMRN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Margin repair and a smaller commercial cost base are reducing cash burn faster than sales are stabilizing.
In FY2025, the company still posted a net loss of-$38.8M , yet operating cash flow turned positive at$6.7M . Because revenue continued to slip while gross margin rebounded from35.6% to56.6% , the improvement looks driven more by margin repair and cost reset than by renewed volume, a sign that accounting losses now overstate the immediate cash drain.
The core operating challenge is scale: FY2025 gross profit was
The balance sheet is cushioning the transition, with cash at
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Amarin's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Amarin has an operating margin of -23.5%, meaning the company retains $-23 of operating profit per $100 of revenue. This below-average margin results in a low score of 24/100, suggesting thin profitability after operating expenses. This is up from -40.2% the prior year.
Amarin's revenue declined 6.5% year-over-year, from $228.6M to $213.6M. This contraction results in a growth score of 6/100.
Amarin has a moderate D/E ratio of 0.46. This balance of debt and equity financing earns a leverage score of 61/100.
With a current ratio of 3.34, Amarin holds $3.34 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 80/100.
Amarin generates a -8.5% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 27/100. This is up from -17.9% the prior year.
Amarin scores -1.78, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($317.1M) relative to total liabilities ($211.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Amarin passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Amarin generates $-0.17 in operating cash flow ($6.7M OCF vs -$38.8M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Amarin earns $-7167.1 in operating income for every $1 of interest expense (-$50.2M vs $7K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Amarin generated $213.6M in revenue in fiscal year 2025. This represents a decrease of 6.5% from the prior year.
Amarin reported -$38.8M in net income in fiscal year 2025. This represents an increase of 55.4% from the prior year.
Amarin earned $-0.09 per diluted share (EPS) in fiscal year 2025. This represents an increase of 55.0% from the prior year.
Cash & Balance Sheet
Amarin held $134.7M in cash against $0 in long-term debt as of fiscal year 2025.
Amarin had 416M shares outstanding in fiscal year 2025. This represents an increase of 1.1% from the prior year.
Margins & Returns
Amarin's gross margin was 56.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 21.0 percentage points from the prior year.
Amarin's operating margin was -23.5% in fiscal year 2025, reflecting core business profitability. This is up 16.7 percentage points from the prior year.
Amarin's net profit margin was -18.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 19.9 percentage points from the prior year.
Amarin's ROE was -8.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 9.4 percentage points from the prior year.
Capital Allocation
Amarin invested $19.8M in research and development in fiscal year 2025. This represents a decrease of 5.1% from the prior year.
AMRN Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $45.1M-8.3% | $49.2M-0.9% | $49.7M-31.7% | $72.7M+73.1% | $42.0M-32.6% | $62.3M+47.3% | $42.3M-37.3% | $67.5M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $17.8M-23.3% | $23.2M+4.3% | $22.2M-55.9% | $50.4M+100.4% | $25.1M+362.7% | -$9.6M-158.8% | $16.3M-61.9% | $42.8M |
| R&D Expenses | $4.7M-13.1% | $5.4M+27.6% | $4.2M-14.4% | $4.9M-7.5% | $5.3M-11.2% | $6.0M+31.8% | $4.5M-4.3% | $4.7M |
| SG&A Expenses | $21.1M+5.3% | $20.1M+1.8% | $19.7M-49.1% | $38.7M+5.7% | $36.6M-1.1% | $37.0M+0.2% | $36.9M-4.3% | $38.5M |
| Operating Income | -$11.3M-79.1% | -$6.3M+43.0% | -$11.1M+30.5% | -$16.0M+4.6% | -$16.8M+68.1% | -$52.5M-108.7% | -$25.2M-4703.1% | -$524K |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $1.8M+382.2% | $371K+198.4% | -$377K-154.7% | $689K-66.7% | $2.1M+260.2% | -$1.3M-135.8% | $3.6M+163.1% | $1.4M |
| Net Income | -$10.5M-757.4% | -$1.2M+84.2% | -$7.7M+45.3% | -$14.1M+9.9% | -$15.7M+70.6% | -$53.4M-112.6% | -$25.1M-1751.4% | $1.5M |
| EPS (Diluted) | $-0.03 | N/A | $-0.02+33.3% | $-0.03+25.0% | $-0.04 | N/A | $-0.06 | $0.00 |
AMRN Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $645.8M-3.7% | $670.8M+1.7% | $659.8M-1.5% | $670.1M+2.2% | $655.7M-4.3% | $685.3M-8.7% | $750.6M-6.2% | $799.9M |
| Current Assets | $626.0M-3.7% | $649.9M+3.4% | $628.3M+3.5% | $606.8M+5.9% | $573.1M-3.8% | $595.4M-8.4% | $650.2M-7.4% | $701.8M |
| Cash & Equivalents | $131.1M-2.7% | $134.7M+9.7% | $122.8M-17.0% | $147.9M+23.7% | $119.5M-1.3% | $121.0M-22.9% | $156.9M-27.3% | $215.9M |
| Inventory | $183.6M-6.3% | $195.9M+6.1% | $184.7M+7.9% | $171.2M+7.4% | $159.5M-3.9% | $166.0M-25.9% | $224.0M-6.4% | $239.4M |
| Accounts Receivable | $108.1M-14.8% | $126.8M-0.4% | $127.3M+6.9% | $119.1M+11.6% | $106.7M-12.7% | $122.3M+8.6% | $112.6M-8.9% | $123.7M |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $196.4M-7.2% | $211.5M+5.3% | $200.9M-2.1% | $205.2M+12.8% | $182.0M-8.6% | $199.2M-9.2% | $219.2M-11.6% | $248.0M |
| Current Liabilities | $179.6M-7.6% | $194.5M+6.7% | $182.2M-2.0% | $185.9M+14.5% | $162.4M-9.7% | $179.9M-10.7% | $201.6M-12.6% | $230.5M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $449.4M-2.1% | $459.3M+0.1% | $458.9M-1.3% | $464.9M-1.8% | $473.7M-2.6% | $486.2M-8.5% | $531.4M-3.7% | $551.9M |
| Retained Earnings | -$1.7B-0.6% | -$1.7B-0.1% | -$1.7B-0.5% | -$1.7B-0.8% | -$1.7B-0.9% | -$1.7B-3.0% | -$1.6B-1.6% | -$1.6B |
AMRN Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.4M-58.2% | $15.3M+220.3% | -$12.7M-176.5% | $16.6M+233.3% | -$12.5M+6.4% | -$13.3M-464.0% | -$2.4M+14.2% | -$2.7M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$8.3M-136.0% | -$3.5M+71.0% | -$12.1M-197.7% | $12.4M+2.9% | $12.1M+152.8% | -$22.8M+59.6% | -$56.6M-1304.5% | $4.7M |
| Financing Cash Flow | -$1.7M-42075.0% | -$4K+98.4% | -$248K+62.6% | -$663K+40.8% | -$1.1M-6682.4% | $17K+125.0% | -$68K-300.0% | $34K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
AMRN Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 39.4%-7.7pp | 47.1%+2.4pp | 44.7%-24.5pp | 69.2%+9.4pp | 59.8%+75.2pp | -15.3%-53.8pp | 38.5%-24.9pp | 63.4% |
| Operating Margin | -25.1%-12.3pp | -12.9%+9.5pp | -22.4%-0.4pp | -22.0%+17.9pp | -39.9%+44.4pp | -84.3%-24.8pp | -59.5%-58.7pp | -0.8% |
| Net Margin | -23.3%-20.8pp | -2.5%+13.1pp | -15.6%+3.9pp | -19.4%+17.9pp | -37.4%+48.4pp | -85.8%-26.3pp | -59.4%-61.7pp | 2.3% |
| Return on Equity | -2.3%-2.1pp | -0.3%+1.4pp | -1.7%+1.4pp | -3.0%+0.3pp | -3.3%+7.7pp | -11.0%-6.3pp | -4.7%-5.0pp | 0.3% |
| Return on Assets | -1.6%-1.4pp | -0.2%+1.0pp | -1.2%+0.9pp | -2.1%+0.3pp | -2.4%+5.4pp | -7.8%-4.5pp | -3.4%-3.5pp | 0.2% |
| Current Ratio | 3.48+0.1 | 3.34-0.1 | 3.45+0.2 | 3.26-0.3 | 3.53+0.2 | 3.31+0.1 | 3.23+0.2 | 3.04 |
| Debt-to-Equity | 0.44-0.0 | 0.46+0.0 | 0.440.0 | 0.44+0.1 | 0.38-0.0 | 0.410.0 | 0.41-0.0 | 0.45 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is Amarin's annual revenue?
Amarin (AMRN) reported $213.6M in total revenue for fiscal year 2025. This represents a -6.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Amarin's revenue growing?
Amarin (AMRN) revenue declined by 6.5% year-over-year, from $228.6M to $213.6M in fiscal year 2025.
Is Amarin profitable?
No, Amarin (AMRN) reported a net income of -$38.8M in fiscal year 2025, with a net profit margin of -18.2%.
What is Amarin's gross margin?
Amarin (AMRN) had a gross margin of 56.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Amarin's operating margin?
Amarin (AMRN) had an operating margin of -23.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Amarin's net profit margin?
Amarin (AMRN) had a net profit margin of -18.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Amarin's return on equity (ROE)?
Amarin (AMRN) has a return on equity of -8.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Amarin's operating cash flow?
Amarin (AMRN) generated $6.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Amarin's total assets?
Amarin (AMRN) had $670.8M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Amarin spend on research and development?
Amarin (AMRN) invested $19.8M in research and development during fiscal year 2025.
What is Amarin's current ratio?
Amarin (AMRN) had a current ratio of 3.34 as of fiscal year 2025, which is generally considered healthy.
What is Amarin's debt-to-equity ratio?
Amarin (AMRN) had a debt-to-equity ratio of 0.46 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Amarin's return on assets (ROA)?
Amarin (AMRN) had a return on assets of -5.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Amarin's Altman Z-Score?
Amarin (AMRN) has an Altman Z-Score of -1.78, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Amarin's Piotroski F-Score?
Amarin (AMRN) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Amarin's earnings high quality?
Amarin (AMRN) has an earnings quality ratio of -0.17x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Amarin cover its interest payments?
Amarin (AMRN) has an interest coverage ratio of -7167.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Amarin?
Amarin (AMRN) scores 33 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.